CoChat

Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Proof of Concept Study

Open access

The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.

Abstract

Cellular therapy is an emerging therapeutic modality with a great potential for the treatment of autism. Recent findings show that the major underlying pathogenetic mechanisms of autism are hypoperfusion and immune alterations in the brain. So conceptually, cellular therapy which facilitates counteractive processes of improving perfusion by angiogenesis and balancing inflammation by immune regulation would exhibit beneficial clinical effects in patients with autism. This is an open label proof of concept study of autologous bone marrow mononuclear cells (BMMNCs) intrathecal transplantation in 32 patients with autism followed by multidisciplinary therapies. All patients were followed up for 26 months (mean 12.7). Outcome measures used were ISAA, CGI, and FIM/Wee-FIM scales. Positron Emission Tomography-Computed Tomography (PET-CT) scan recorded objective changes. Out of 32 patients, a total of 29 (91%) patients improved on total ISAA scores and 20 patients (62%) showed decreased severity on CGI-I. The difference between pre- and postscores was statistically significant (P<0.001) on Wilcoxon matched-pairs signed rank test. On CGI-II 96% of patients showed global improvement. The efficacy was measured on CGI-III efficacy index. Few adverse events including seizures in three patients were controlled with medications. The encouraging results of this leading clinical study provide future directions for application of cellular therapy in autism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2013/623875

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Frequency distribution of participants on CGI-II scale. This figure shows the percentage of people showing varying degrees of improvement after cellular transplantation.
Figure 1 Frequency distribution of participants on CGI-II scale. This figure shows the percentage of people showing varying degrees of improvement after cellular transplantation.CC BY · PubMed Central
Figure 2 Frequency distribution of the participants on the CGI-III scale. This figure demonstrates the percentage of people on varying degrees of efficacy of the intervention. This takes into consideration the side effects and the benefits observed.
Figure 2 Frequency distribution of the participants on the CGI-III scale. This figure demonstrates the percentage of people on varying degrees of efficacy of the intervention. This takes into consideration the side effects and the benefits observed.CC BY · PubMed Central
Figure 3 Schematic representation of clinical improvements after cellular therapy. This figure shows proposed theoretical outline of observed changes after cellular therapy.
Figure 3 Schematic representation of clinical improvements after cellular therapy. This figure shows proposed theoretical outline of observed changes after cellular therapy.CC BY · PubMed Central
Figure 4 Findings in PET-CT scan before and after cellular therapy. (a) PET-CT scan before intervention showing reduced FDG uptake in the areas of frontal lobe, cerebellum, amygdala, hippocampus, parahippocampus, and mesial temporal lobe. (b) PET-CT scan six months after intervention comparison shows increased FDG uptake in the areas of frontal lobe, cerebellum, amygdala, hippocampus, parahippocampus, and mesial temporal lobe.
Figure 4 Findings in PET-CT scan before and after cellular therapy. (a) PET-CT scan before intervention showing reduced FDG uptake in the areas of frontal lobe, cerebellum, amygdala, hippocampus, parahippocampus, and mesial temporal lobe. (b) PET-CT scan six months after intervention comparison shows increased FDG uptake in the areas of frontal lobe, cerebellum, amygdala, hippocampus, parahippocampus, and mesial temporal lobe.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 109 references

Research works printed but not linked: 6

  1. 2012, Autism, 2, 2
  2. 2012, Indian Journal of Medical Research, 136, 221
  3. 2013, Journal of Translational Medicine, 26, 21
  4. 2010, Alternative Medicine Review, 15, 15
  5. 2006, Cell Molecular Neurobiology, 26, 1113
  6. 2002, Orvosi hetilap, 143, 1302

Cited by

See all 114

Metadata

Authors
Sharma, A., Gokulchandran, N., Sane, H., Nagrajan, A., Paranjape, A., Kulkarni, P., Shetty, A., Mishra, P., Kali, M., Biju, H., & Badhe, P.
Affiliations
Neurogen Brain & Spine Institute (IN)
Corresponding author
Kulkarni, Pooja
Venue
Stem Cells International
Publisher
Wiley
Published
2013
Volume
2013
Pages
1-13
ISSN
  • 1687-966X (ISSN-L)
  • 1687-9678
OpenAlex
W2105688599
Cited by
110
References
108
Citations by year
2026: 4 · 2025: 6 · 2024: 8 · 2023: 8 · 2022: 8 · 2021: 12 · 2020: 13 · 2019: 7 · 2018: 6 · 2017: 6 · 2016: 7 · 2015: 16 · 2014: 7 · 2013: 2
FWCI
5.85
Type
journal article
Language
en
Open access
Locations
  • Stem Cells International (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
autism spectrum disorder, autologous bone marrow mononuclear cells, cell therapy, intrathecal transplantation, cerebral hypoperfusion, angiogenesis, neuroinflammation, immune regulation, functional outcome, adverse events, seizures

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Proof of Concept Study. https://app.cochat.ai/papers/10.1155/2013/623875
The paper
Sharma, A., Gokulchandran, N., Sane, H., Nagrajan, A., Paranjape, A., Kulkarni, P., Shetty, A., Mishra, P., Kali, M., Biju, H., & Badhe, P. (2013). Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Proof of Concept Study. Stem Cells International. https://doi.org/10.1155/2013/623875

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.